We are live on ! Find out more
HOOK

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

72 hedge funds and large institutions have $32.7M invested in HOOKIPA Pharma in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 21

0.51% more ownership

Funds ownership: 4.86%5.37% (+0.51%)

0% more funds holding

Funds holding: 7272 (0)

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

28% less call options, than puts

Call options by funds: $64K | Put options by funds: $89K

56% less capital invested

Capital invested by funds: $74.2M → $32.7M (-$41.4M)

Holders
72
Holders Change
Holders Change %
0%
% of All Funds
1.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
23
Reduced
21
Closed
13
Calls
$64K
Puts
$89K
Net Calls
-$25K
Net Calls Change
+$284K
Name Holding Trade Value Shares
Change
Change in
Stake
ASN
76
Advisory Services Network
Georgia
-$70K -1,180 Closed
Jane Street
77
Jane Street
New York
-$64K -1,099 Closed
LPL Financial
78
LPL Financial
California
-$62K -1,050 Closed
Simplex Trading
79
Simplex Trading
Illinois
-$33.6K -835 Closed
TWA
80
TCI Wealth Advisors
Arizona
-$2K -26 Closed
JMF
81
Johnson Midwest Financial
Iowa
-$1K -19 Closed
BHWM
82
Beaird Harris Wealth Management
Texas
+$362 +9 New

HOOK Hedge Fund Activity: Q4 2021 in Review

72 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2021, worth a combined $32.7M — down 56% from $74.2M a quarter earlier.

Fund positioning in HOOK was balanced in Q4 2021: 13 funds opened new positions, 13 closed out, 23 added to existing stakes and 21 trimmed.

The largest buyer was Bank of America, adding an estimated $2.7M. The largest seller was Woodline Partners, exiting entirely with an estimated $3.97M sold.

  • 72 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $32.7M of HOOKIPA Pharma stock for Q4 2021, down 56% quarter-over-quarter.
  • 13 funds opened new HOOKIPA Pharma positions in Q4 2021 and 13 closed out, a net change of 0 holders.
  • The largest HOOKIPA Pharma buyer in Q4 2021 was Bank of America, an estimated $2.7M added.
  • The largest HOOKIPA Pharma seller in Q4 2021 was Woodline Partners, an estimated $3.97M sold.

Based on aggregated 13F filings for Q4 2021.